Skip to main content
Equibles

NATIONAL BANK OF CANADA /FI/

Bank

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 926171 MONTREAL, A8
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$2,714,445
+$2,708,806 QoQ
Shares Held
739,631
+40163.0% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 344 holders
Holding Since
Jun 2022
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NATIONAL BANK OF CANADA /FI/ holds $632,429,861 across 151 Biotechnology names. RXRX ranks #13 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 1,096,025 $205,263,562
2 MRNA
Moderna, Inc.
 1,424,802 $99,778,883
3 ROIV
Roivant Sciences Ltd.
 2,773,874 $98,167,400
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 172,898 $85,883,622
5 REGN
Regeneron Pharmaceuticals, Inc.
 125,812 $78,448,813
6 ALNY
Alnylam Pharmaceuticals, Inc.
 52,467 $15,794,140
7 GPCR
Structure Therapeutics Inc.
 215,800 $11,581,986
8 ABCL
AbCellera Biologics Inc.
 1,233,014 $9,679,159

All Filings in RXRX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,714,445 739,631
2026-03-31 $5,639 1,837
2025-12-31 $3,581,097 875,574
2025-09-30 $24,839 5,090
2025-06-30 $306,636 60,600
2025-03-31 $372,416 70,400
2024-12-31 $116,948 17,300
2024-06-30 $1,500 200
2024-03-31 $11,964 1,200
2023-12-31 $31,059 3,150
2023-09-30 $12,622 1,650
2023-06-30 $1,120 150
2023-03-31 $1,000 150
2022-09-30 $10,640 1,000
2022-06-30 $24,420 3,000